Thursday, June 20, 2024
HomeBusinessBoeing, Intellia Therapeutics, Perion Network & more

Boeing, Intellia Therapeutics, Perion Network & more

Date:

Related stories

Maximize your claim settlement: Hire an injury lawyer in Salt Lake City

Imagine this – You were driving as usual in Salt...

3 Ways in Which Search Engine Optimisation Could Boost Traffic Numbers To Your Website

In the constantly evolving and fast-paced digital landscape at...

127.0.0.1:49342: A Comprehensive Guide To Localhost, Fixing, Configuring and Working

Technology has numerous terms that have unique importance and...

Which DNA test is the most reliable for determining paternity?

When it comes to determining paternity, DNA tests are the...

[ad_1]

Take a look at some of the biggest movers in the premarket:

Boeing (BA) – Boeing is not likely to receive certification for its 777X long-range aircraft until mid-to-late 2023 at the earliest. That’s according to a letter from a Federal Aviation Administration official to Boeing that was obtained by CNBC, saying there were numerous technical issues that needed to be resolved. Boeing shares fell 1.2% in the premarket.

Intellia Therapeutics (NTLA) – Intellia shares surged 55.4% in the premarket after the Massachusetts-based company and partner Regeneron (REGN) announced positive results in a phase 1 study of a gene-editing treatment for a disease called transthyretin amyloidosis. Regeneron shares gained 1.6%. Two other companies involved with the same gene-editing technology also rallied in premarket trading, with CRISPR Therapeutics (CRSP) soaring 13.5% and Editas Medicine (EDIT) jumping 17.1%.

Perion Network (PERI) – The advertising technology company’s shares surged 9.9% in the premarket after reporting upbeat second-quarter earnings and increasing its full-year forecast.

Johnson & Johnson (JNJ) – Johnson & Johnson will pay $263 million to resolve opioid-related claims in a settlement involving both the state and Nassau and Suffolk Counties. The settlement – in which J&J does not admit or deny guilt – removes the company from an opioid trial set to begin Tuesday.

Tesla (TSLA) – Tesla is virtually recalling nearly 300,000 cars to implement a software update related to assisted driving. The owners will not actually have to return the vehicles in order to receive the update.

Biogen (BIIB) – House lawmakers announced an inquiry into the process that approved Biogen’s Alzheimer’s treatment as well as its pricing. Biogen told Reuters it would cooperate with any inquiries it received from lawmakers.

See also  U.S. looks into having 3 Central Asian states take in at-risk Afghans -sources By Reuters

Nvidia (NVDA) – Nvidia received support for its planned $40 billion takeover of ARM from some of the U.K. chip maker’s major customers, according to a report in the Sunday Times. The public display of support comes from Broadcom (AVGO), Marvell (MRVL) and MediaTek.

MetLife (MET) – MetLife received an offer from Netherlands-based insurer NN Group for some of MetLife’s European businesses, though NN did not say which businesses were involved or how much it had offered.

MicroStrategy (MSTR) – The business analytics company’s stock gained 3.3% in premarket trading, continuing to trade in sync with bitcoin. MicroStrategy has several billion dollars of the virtual currency on its books.

Ocwen Financial (OCN), JOANN (JOAN) – Both stocks will be included in the small-cap Russell 2000 index as of today. Ocwen is a mortgage origination and servicing company, while JOANN is an arts and crafts retailer.

NRG Energy (NRG) – The energy provider’s stock was added to the Conviction Buy list at Goldman Sachs, which also increased its price target on the stock to $57 per share from $46. The stock closed at $38.49 per share Friday, and gained 1.8% in premarket trading.

[ad_2]

Source link

Bellie Brown
Bellie Brownhttps://businesstimes.org
Hi my lovely readers, I am Bellie brown editor and writer of Businesstimes.org. I write blogs on various niches such as business, technology, lifestyle., health, entertainment, etc as well as manage the daily reports of the website. I am very addicted to my work which makes me keen on reading and writing on the very latest and trending topics. One can check my more writings by visiting Cleartips.net

Latest stories